MedTrace Logo

24-Hour NAVA Ventilation in Acute Respiratory Failure

NCT00583037 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 15

Last updated 2009-06-01

No results posted yet for this study

Summary

Neurally Adjusted Ventilatory Assist (NAVA) is a new mode of mechanical ventilation that is controlled by the electrical activity of the diaphragm (EAdi). The EAdi is a signal that represents the patient's breathing effort, and hence with NAVA, the assist being delivered is synchronized and proportional to the demands of the patient. This is a prospective physiological study of the feasibility of NAVA ventilation over 24 hours. The aim is to demonstrate that NAVA can maintain spontaneous breathing and unload the respiratory muscles during both sleep and wake cycles over a 24 hour period.

Conditions

  • Respiration, Artificial
  • Respiratory Insufficiency

Interventions

DEVICE

Neurally Adjusted Ventilatory Assist (NAVA)

Mechanical ventilation controlled by diaphragm electrical activity

Sponsors & Collaborators

  • Unity Health Toronto

    lead OTHER

Principal Investigators

  • Fabrice Brunet, MD · Unity Health Toronto

  • Christer Sinderby, PhD · Unity Health Toronto

Study Design

Allocation
NA
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-05-31
Primary Completion
2008-01-31
Completion
2008-05-31

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00583037 on ClinicalTrials.gov